NIAID launches three new AIDS vaccine trials. National Institute of Allergy and Infectious Diseases.
Doepel
L K
LK
D016915:AIDS Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D000917:Antibody Formation; D017321:Clinical Trials, Phase I as Topic; D018014:Gene Transfer Techniques; D005814:Genes, Viral; D006678:HIV / Q000235:genetics; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007111:Immunity, Cellular; D009092:Mucous Membrane / Q000276:immunology
D016915:AIDS Vaccines